These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 19255432)
1. Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. Lu TK; Collins JJ Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4629-34. PubMed ID: 19255432 [TBL] [Abstract][Full Text] [Related]
2. Quinolone Resistance Reversion by Targeting the SOS Response. Recacha E; Machuca J; Díaz de Alba P; Ramos-Güelfo M; Docobo-Pérez F; Rodriguez-Beltrán J; Blázquez J; Pascual A; Rodríguez-Martínez JM mBio; 2017 Oct; 8(5):. PubMed ID: 29018116 [TBL] [Abstract][Full Text] [Related]
3. Bacteriophage-antibiotic combinations against ciprofloxacin/ceftriaxone-resistant Escherichia coli in vitro and in an experimental Galleria mellonella model. Wang L; Tkhilaishvili T; Bernal Andres B; Trampuz A; Gonzalez Moreno M Int J Antimicrob Agents; 2020 Dec; 56(6):106200. PubMed ID: 33075514 [TBL] [Abstract][Full Text] [Related]
4. Temperate phage-antibiotic synergy across antibiotic classes reveals new mechanism for preventing lysogeny. Al-Anany AM; Fatima R; Nair G; Mayol JT; Hynes AP mBio; 2024 Jun; 15(6):e0050424. PubMed ID: 38757974 [TBL] [Abstract][Full Text] [Related]
5. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR mBio; 2017 Oct; 8(5):. PubMed ID: 29089428 [TBL] [Abstract][Full Text] [Related]
6. Prophages and Growth Dynamics Confound Experimental Results with Antibiotic-Tolerant Persister Cells. Harms A; Fino C; Sørensen MA; Semsey S; Gerdes K mBio; 2017 Dec; 8(6):. PubMed ID: 29233898 [TBL] [Abstract][Full Text] [Related]
8. N-acetylcysteine blocks SOS induction and mutagenesis produced by fluoroquinolones in Escherichia coli. Rodríguez-Rosado AI; Valencia EY; Rodríguez-Rojas A; Costas C; Galhardo RS; Rodríguez-Beltrán J; Blázquez J J Antimicrob Chemother; 2019 Aug; 74(8):2188-2196. PubMed ID: 31102529 [TBL] [Abstract][Full Text] [Related]
9. Susceptibility of Escherichia coli isolated from uteri of postpartum dairy cows to antibiotic and environmental bacteriophages. Part II: In vitro antimicrobial activity evaluation of a bacteriophage cocktail and several antibiotics. Santos TM; Gilbert RO; Caixeta LS; Machado VS; Teixeira LM; Bicalho RC J Dairy Sci; 2010 Jan; 93(1):105-14. PubMed ID: 20059909 [TBL] [Abstract][Full Text] [Related]
10. Suppression of the SOS response modifies spatiotemporal evolution, post-antibiotic effect, bacterial fitness and biofilm formation in quinolone-resistant Escherichia coli. Recacha E; Machuca J; Díaz-Díaz S; García-Duque A; Ramos-Guelfo M; Docobo-Pérez F; Blázquez J; Pascual A; Rodríguez-Martínez JM J Antimicrob Chemother; 2019 Jan; 74(1):66-73. PubMed ID: 30329046 [TBL] [Abstract][Full Text] [Related]
11. p-Coumaric acid inhibits the Listeria monocytogenes RecA protein functions and SOS response: An antimicrobial target. Ojha D; Patil KN Biochem Biophys Res Commun; 2019 Oct; 517(4):655-661. PubMed ID: 31416617 [TBL] [Abstract][Full Text] [Related]
12. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli. Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884 [TBL] [Abstract][Full Text] [Related]
13. SOS response induces persistence to fluoroquinolones in Escherichia coli. Dörr T; Lewis K; Vulić M PLoS Genet; 2009 Dec; 5(12):e1000760. PubMed ID: 20011100 [TBL] [Abstract][Full Text] [Related]
14. Cyclic AMP Regulates Bacterial Persistence through Repression of the Oxidative Stress Response and SOS-Dependent DNA Repair in Uropathogenic Molina-Quiroz RC; Silva-Valenzuela C; Brewster J; Castro-Nallar E; Levy SB; Camilli A mBio; 2018 Jan; 9(1):. PubMed ID: 29317513 [TBL] [Abstract][Full Text] [Related]
15. Modified Antibiotic Adjuvant Ratios Can Slow and Steer the Evolution of Resistance: Co-amoxiclav as a Case Study. Allen RC; Brown SP mBio; 2019 Sep; 10(5):. PubMed ID: 31530673 [TBL] [Abstract][Full Text] [Related]
16. A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota. Cieplak T; Soffer N; Sulakvelidze A; Nielsen DS Gut Microbes; 2018; 9(5):391-399. PubMed ID: 29517960 [TBL] [Abstract][Full Text] [Related]
17. Silencing of antibiotic resistance in E. coli with engineered phage bearing small regulatory RNAs. Libis VK; Bernheim AG; Basier C; Jaramillo-Riveri S; Deyell M; Aghoghogbe I; Atanaskovic I; Bencherif AC; Benony M; Koutsoubelis N; Löchner AC; Marinkovic ZS; Zahra S; Zegman Y; Lindner AB; Wintermute EH ACS Synth Biol; 2014 Dec; 3(12):1003-6. PubMed ID: 25524110 [TBL] [Abstract][Full Text] [Related]
18. Role of LsrR in the regulation of antibiotic sensitivity in avian pathogenic Escherichia coli. Yu L; Li W; Li Q; Chen X; Ni J; Shang F; Xue T Poult Sci; 2020 Jul; 99(7):3675-3687. PubMed ID: 32616264 [TBL] [Abstract][Full Text] [Related]
19. The designer proline-rich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models. Szabo D; Ostorhazi E; Binas A; Rozgonyi F; Kocsis B; Cassone M; Wade JD; Nolte O; Otvos L Int J Antimicrob Agents; 2010 Apr; 35(4):357-61. PubMed ID: 20031377 [TBL] [Abstract][Full Text] [Related]
20. Phage-delivered sensitisation with subsequent antibiotic treatment reveals sustained effect against antimicrobial resistant bacteria. Liu H; Li H; Liang Y; Du X; Yang C; Yang L; Xie J; Zhao R; Tong Y; Qiu S; Song H Theranostics; 2020; 10(14):6310-6321. PubMed ID: 32483454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]